Literature DB >> 23354788

Extraintestinal manifestations in an infant with microvillus inclusion disease: complications or features of the disease?

Tania Siahanidou1, Eirini Koutsounaki, Anna-Venetia Skiathitou, Kalliopi Stefanaki, Evangelos Marinos, Ioanna Panajiotou, Giorgos Chouliaras.   

Abstract

UNLABELLED: Microvillus inclusion disease (MVID), a rare severe congenital enteropathy characterized by intracytoplasmic microvillous inclusions and variable brush border atrophy on intestinal epithelial cells histology, is associated with defective synthesis or abnormal function of the motor protein myosin Vb encoded by the MYO5B gene. Although MYO5B gene is expressed in all epithelial tissues, it is unclear so far whether organs other than intestine are affected in MVID patients. We report a case of an infant with MVID who presented liver dysfunction, hematuria, and Pneumocystis jiroveci pneumonia during the course of the disease. It is discussed whether extraintestinal manifestations in this patient are secondary consequences of MVID or might be features of the disease associated with altered MYO5B function.
CONCLUSIONS: MVID is classically included in the differential diagnosis of congenital diarrhea of secretory type. Recent advances in our knowledge regarding the role of myosin Vb in the pathophysiology of MVID is expected to clarify the clinical spectrum of the disease and the possible primary involvement of organs other than intestine.

Entities:  

Mesh:

Year:  2013        PMID: 23354788     DOI: 10.1007/s00431-013-1948-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Preventing parenteral nutrition liver disease.

Authors:  Deirdre A Kelly
Journal:  Early Hum Dev       Date:  2010-11       Impact factor: 2.079

Review 2.  Enteropathies associated with protracted diarrhea of infancy: clinicopathological features, cellular and molecular mechanisms.

Authors:  E Cutz; P M Sherman; G P Davidson
Journal:  Pediatr Pathol Lab Med       Date:  1997 May-Jun

3.  MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.

Authors:  Magdalena R Golachowska; Carin M L van Dael; Hilda Keuning; Arend Karrenbeld; Dick Hoekstra; Carolien F M Gijsbers; Marc A Benninga; Edmond H H M Rings; Sven C D van Ijzendoorn
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-04       Impact factor: 2.839

4.  Rab11a and myosin Vb are required for bile canalicular formation in WIF-B9 cells.

Authors:  Yoshiyuki Wakabayashi; Parmesh Dutt; Jennifer Lippincott-Schwartz; Irwin M Arias
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-07       Impact factor: 11.205

5.  Microvillous inclusion disease: how to improve the prognosis of a severe congenital enterocyte disorder.

Authors:  Ugur Halac; Florence Lacaille; Francisca Joly; Jean-Pierre Hugot; Cécile Talbotec; Virginie Colomb; Frank M Ruemmele; Olivier Goulet
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-04       Impact factor: 2.839

6.  Familial microvillous atrophy: a clinicopathological survey of 23 cases.

Authors:  A D Phillips; J Schmitz
Journal:  J Pediatr Gastroenterol Nutr       Date:  1992-05       Impact factor: 2.839

7.  Rab11-family interacting protein 2 and myosin Vb are required for CXCR2 recycling and receptor-mediated chemotaxis.

Authors:  Guo-Huang Fan; Lynne A Lapierre; James R Goldenring; Jiqing Sai; Ann Richmond
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

8.  MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity.

Authors:  Thomas Müller; Michael W Hess; Natalia Schiefermeier; Kristian Pfaller; Hannes L Ebner; Peter Heinz-Erian; Hannes Ponstingl; Joachim Partsch; Barbara Röllinghoff; Henrik Köhler; Thomas Berger; Henning Lenhartz; Barbara Schlenck; Roderick J Houwen; Christopher J Taylor; Heinz Zoller; Silvia Lechner; Olivier Goulet; Gerd Utermann; Frank M Ruemmele; Lukas A Huber; Andreas R Janecke
Journal:  Nat Genet       Date:  2008-08-24       Impact factor: 38.330

Review 9.  Congenital diarrheal disorders: an updated diagnostic approach.

Authors:  Gianluca Terrin; Rossella Tomaiuolo; Annalisa Passariello; Ausilia Elce; Felice Amato; Margherita Di Costanzo; Giuseppe Castaldo; Roberto Berni Canani
Journal:  Int J Mol Sci       Date:  2012-03-29       Impact factor: 6.208

Review 10.  Microvillous inclusion disease (microvillous atrophy).

Authors:  Frank M Ruemmele; Jacques Schmitz; Olivier Goulet
Journal:  Orphanet J Rare Dis       Date:  2006-06-26       Impact factor: 4.123

View more
  6 in total

1.  Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.

Authors:  Amy C Engevik; Alexander W Coutts; Izumi Kaji; Paula Rodriguez; Felipe Ongaratto; Milena Saqui-Salces; Ramya Lekha Medida; Anne R Meyer; Elena Kolobova; Melinda A Engevik; Janice A Williams; Mitchell D Shub; Daniel F Carlson; Tamene Melkamu; James R Goldenring
Journal:  Gastroenterology       Date:  2020-02-26       Impact factor: 22.682

2.  Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management.

Authors:  Sarah K Baxter; Tom Walsh; Silvia Casadei; Mary M Eckert; Eric J Allenspach; David Hagin; Gesmar Segundo; Ming K Lee; Suleyman Gulsuner; Brian H Shirts; Kathleen E Sullivan; Michael D Keller; Troy R Torgerson; Mary-Claire King
Journal:  J Allergy Clin Immunol       Date:  2021-04-20       Impact factor: 10.793

3.  Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.

Authors:  Yi-Ling Qiu; Jing-Yu Gong; Jia-Yan Feng; Ren-Xue Wang; Jun Han; Teng Liu; Yi Lu; Li-Ting Li; Mei-Hong Zhang; Jonathan A Sheps; Neng-Li Wang; Yan-Yan Yan; Jia-Qi Li; Lian Chen; Christoph H Borchers; Bence Sipos; A S Knisely; Victor Ling; Qing-He Xing; Jian-She Wang
Journal:  Hepatology       Date:  2017-03-23       Impact factor: 17.425

Review 4.  Unequal Effects of Myosin 5B Mutations in Liver and Intestine Determine the Clinical Presentation of Low-Gamma-Glutamyltransferase Cholestasis.

Authors:  Sven C D van IJzendoorn; Qinghong Li; Yi-Ling Qiu; Jian-She Wang; Arend W Overeem
Journal:  Hepatology       Date:  2020-10       Impact factor: 17.425

5.  A Novel Homozygous Mutation in the MYO5B Gene Associated With Normal-Gamma-Glutamyl Transferase Progressive Familial Intrahepatic Cholestasis.

Authors:  Nihal Uyar Aksu; Orhan Görükmez; Özlem Görükmez; Ayşen Uncuoğlu
Journal:  Cureus       Date:  2021-11-07

Review 6.  Recent advances in understanding and managing malabsorption: focus on microvillus inclusion disease.

Authors:  Dulari Jayawardena; Waddah A Alrefai; Pradeep K Dudeja; Ravinder K Gill
Journal:  F1000Res       Date:  2019-12-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.